title: [Therapy of seborrheic eczema with an antifungal agent with an antiphlogistic effect].
abstract: Numerous AIDS patients show the typical seborrheic eczema in a very prominent way. For this is an inflammatory disease, combination preparations were taken frequently which contain antimycotics and corticosteroids. We investigated 7 antimycotic compounds in 3 inflammatory models: amorolfin, ciclopiroxolamine (cic), fluconazole, ketoconazole, miconazole, naftifine, and rilopirox. In an in vitro model the inflammatory activity towards the 5-lipoxygenase was investigated. 1,000 mumol naftifine, 100 mumol ketoconazole, 50 mumol cic, and 10 mumol rilopirox inhibited 5-HETE by 90%. In a cell culture model only cic had a significant activity towards cyclo-oxygenase. In this model the inhibition of the prostaglandin E2 liberation by 1 mumol cic was 40%. In an in vivo model the anti-inflammatory activity on a mouse ear was investigated (arachidonic acid induced). In this model only cic showed a significant inhibition of inflammation (50%) at 1 mg/ear. These investigations show, that cic has a strong antiphlogistic activity. In an open clinical trial with 20 patients suffering from seborrheic eczema after 4 weeks on cic cream a strong inhibition of infiltration and flakiness had been observed. The antimycotic compound cic offers a possibility to treat inflammatory mycoses without using corticosteroid combinations. In a double blind clinical trial (tinea) where cic was compared with a cic/hydrocortisone combination no statistical differences were found.
authors.affiliation: Hoechst AG, Frankfurt/Main.
authors.forename: H
authors.initials: H
authors.lastname: Hänel
authors.forename: E
authors.initials: E
authors.lastname: Smith-Kurtz
authors.forename: S
authors.initials: S
authors.lastname: Pastowsky
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077768:Ciclopirox; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D011728:Pyridones; D000077768:Ciclopirox; D006854:Hydrocortisone
vernacular_title: Therapie des seborrhoischen Ekzems mit einem antiphlogistisch wirksamen Antimykotikum.